Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maralixibat for the trEatment of inTrAhePatic cHOlestasis of pRegnancy (METAPHOR)

NCT07389031 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07389031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07389031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maralixibat for the trEatment of inTrAhePatic cHOlestasis of pRegnancy (METAPHOR)
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
March 31, 2028
Enrollment
28 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

intrahepatic cholestasis of pregnancy